Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

NYXH

Nyxoah SA

Apr 19 • 04:00PM ET

10.75

Dollar change +0.35
Percentage change 3.37	%

Healthcare • Medical Instruments & Supplies • Belgium • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: BMED

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.68	Insider Own	67.69%	Shs Outstand	28.67M	Perf Week	19.31%
Market Cap	308.10M	Forward P/E	-	EPS next Y	-1.93	Insider Trans	0.00%	Shs Float	9.26M	Perf Month	-22.66%
Income	-46.70M	PEG	-	EPS next Q	-0.46	Inst Own	11.87%	Short Float	2.78%	Perf Quarter	138.62%
Sales	4.70M	P/S	65.55	EPS this Y	-12.13%	Inst Trans	-	Short Ratio	4.31	Perf Half Y	55.57%
Book/sh	3.78	P/B	2.84	EPS next Y	-2.29%	ROA	-31.87%	Short Interest	0.26M	Perf Year	47.06%
Cash/sh	2.23	P/C	4.83	EPS next 5Y	-	ROE	-39.44%	52W Range	4.00 - 20.00	Perf YTD	131.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-27.28%	ROI	-38.57%	52W High	-46.25%	Beta	1.65
Dividend TTM	-	Quick Ratio	4.53	Sales past 5Y	289.43%	Gross Margin	7.68%	52W Low	168.75%	ATR (14)	1.28
Dividend Ex-Date	-	Current Ratio	4.76	EPS Y/Y TTM	-32.37%	Oper. Margin	-1049.78%	RSI (14)	43.83	Volatility	11.83% 10.28%
Employees	-	Debt/Eq	0.13	Sales Y/Y TTM	44.57%	Profit Margin	-993.40%	Recom	1.50	Target Price	20.41
Option/Short	No / No	LT Debt/Eq	0.12	EPS Q/Q	22.15%	Payout	-	Rel Volume	0.44	Prev Close	10.40
Sales Surprise	5.49%	EPS Surprise	-6.77%	Sales Q/Q	47.13%	Earnings	Mar 05 AMC	Avg Volume	59.82K	Price	10.75
SMA20	-8.10%	SMA50	-20.85%	SMA200	27.47%	Trades		Volume	26,084	Change	3.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-23	Initiated	H.C. Wainwright	Buy
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-21-22	Initiated	Oppenheimer	Outperform	$30
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$21
Dec-21-21	Resumed	Cantor Fitzgerald	Overweight	$47
Jul-28-21	Initiated	Cantor Fitzgerald	Overweight	$43

Apr-11-24 04:30PM	Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer (GlobeNewswire) -10.41%
Mar-29-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Mar-25-24 02:05AM	Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology Head & Neck Surgery Foundation (GlobeNewswire) -7.88%
Mar-19-24 04:05PM	Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints (GlobeNewswire) -14.21%
Mar-07-24 09:45AM	Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.22%
09:52PM	Loading…
Mar-05-24 09:52PM	NYXH Stock Earnings: Nyxoah Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -5.24%
04:05PM	Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results (GlobeNewswire)
Feb-29-24 04:30PM	Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-15-24 04:30PM	Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 (GlobeNewswire) +7.32%
Jan-17-24 04:05PM	Nyxoah Announces 2024 Strategic Priorities (GlobeNewswire) -6.04%
Jan-09-24 04:05PM	Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 (GlobeNewswire)
Dec-11-23 01:30AM	Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio (GlobeNewswire)
Dec-08-23 04:30PM	Publication Relating to a Transparency Notification (GlobeNewswire)
Nov-28-23 04:30PM	Nyxoah Strengthens its Executive Leadership Team (GlobeNewswire)
Nov-27-23 08:19AM	Why Is Nyxoah (NYXH) Stock Up 4% Today? (InvestorPlace)
04:30PM	Loading…
Nov-21-23 04:30PM	Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-08-23 04:05PM	Nyxoah Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Nov-07-23 04:30PM	Nyxoah to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-26-23 04:30PM	Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 (GlobeNewswire)
Sep-28-23 04:30PM	Nyxoah Announces Partnership with ResMed in Germany (GlobeNewswire)
Sep-12-23 04:30PM	Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-05-23 04:30PM	Nyxoah to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-30-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
Aug-08-23 04:05PM	Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results (GlobeNewswire)
Jul-27-23 04:30PM	Publication Relating to a Transparency Notification (GlobeNewswire)
04:30PM	Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
04:30PM	Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference (GlobeNewswire)
04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
May-16-23 04:05PM	Nyxoah Reports First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-12-23 01:00AM	Invitation to Attend the Annual Shareholders Meeting of the Company to be Held on June 14, 2023 (GlobeNewswire)
04:05PM	Loading…
May-10-23 04:05PM	Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer (GlobeNewswire)
May-01-23 04:30PM	Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023 (GlobeNewswire) +7.79%
Apr-20-23 04:30PM	Publication Relating to Transparency Notifications (GlobeNewswire)
Apr-17-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire) +10.01%
Apr-13-23 04:05PM	Nyxoah Raises $3 Million from its At-the-Market Equity Offering (GlobeNewswire) +10.19%
Mar-31-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
Mar-27-23 04:05PM	Nyxoah Raises $3 Million from an At-the-Market Equity Offering (GlobeNewswire)
Mar-23-23 04:05PM	Nyxoah Announces a $15 Million Private Placement Financing (GlobeNewswire)
Mar-22-23 04:05PM	Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-08-23 04:30PM	Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Mar-07-23 04:30PM	Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Mar-06-23 01:30AM	Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones (GlobeNewswire)
Feb-22-23 06:00AM	Nyxoah Announces Inaugural Investor & Analyst Meeting (GlobeNewswire) +10.75%
Feb-21-23 04:30PM	Nyxoah Announces Inaugural Investor & Analyst Meeting (GlobeNewswire) -6.82%
Jan-09-23 04:30PM	Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors (GlobeNewswire)
Dec-29-22 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Dec-22-22 04:12PM	Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program (GlobeNewswire)
Nov-17-22 04:30PM	Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-16-22 09:55AM	Wall Street Analysts See a 240% Upside in Nyxoah SA (NYXH): Can the Stock Really Move This High? (Zacks)
Nov-08-22 04:05PM	Nyxoah Reports Third Quarter 2022 Financial and Operating Results (GlobeNewswire)
Oct-24-22 04:30PM	Nyxoah Announces Change to Board of Directors (GlobeNewswire)
Oct-20-22 04:30PM	Nyxoah to Participate in the Jefferies London Healthcare Conference (GlobeNewswire) -8.14%
Oct-18-22 04:30PM	Nyxoah to Release Third Quarter Financial Results on November 8, 2022 (GlobeNewswire)
Sep-30-22 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Aug-18-22 04:30PM	Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference (GlobeNewswire)
Aug-11-22 09:55AM	Wall Street Analysts Believe Nyxoah SA (NYXH) Could Rally 170%: Here's is How to Trade (Zacks)
Aug-08-22 11:00PM	Nyxoah S.A. (NYXH) Q2 2022 Earnings Call Transcript (Motley Fool)
04:05PM	Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results (GlobeNewswire)
Aug-04-22 10:25AM	CareCloud, Inc. (MTBC) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-02-22 02:00AM	Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test (GlobeNewswire)
Jul-27-22 04:30PM	Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
Jul-19-22 04:30PM	Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022 (GlobeNewswire) +12.22%
06:47AM	Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea (Benzinga)
Jul-18-22 04:30PM	Nyxoah Announces CE Mark Approval for Genio® 2.1 (GlobeNewswire)
Jul-12-22 08:14AM	Nyxoah SA (NYXH) Stock Jumps 13.2%: Will It Continue to Soar? (Zacks)
Jul-11-22 09:34AM	FDA Signs Off Nyxoah's Genio Trial In Complete Concentric Collapse Patients (Benzinga) +13.24%
02:00AM	Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients (GlobeNewswire)
Jun-30-22 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) -8.64%
Jun-07-22 04:30PM	Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index (GlobeNewswire)
Jun-01-22 04:30PM	FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study (GlobeNewswire) -6.46%
May-10-22 02:55AM	Nyxoah Reports First Quarter 2022 Financial and Operating Results (GlobeNewswire)
May-09-22 04:30PM	Nyxoah Reports First Quarter 2022 Financial and Operating Results (GlobeNewswire) -8.82%
May-06-22 06:53AM	2 Stocks Oppenheimer Sees Surging Over 80% (TipRanks) +7.87%
01:00AM	Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors (GlobeNewswire)
01:00AM	Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 8, 2022 (GlobeNewswire)
Apr-28-22 04:30PM	Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022 (GlobeNewswire)
Mar-25-22 08:30PM	Nyxoah S.A. (NYXH) Q4 2021 Earnings Call Transcript (Motley Fool)
Mar-24-22 04:30PM	Nyxoah Reports Full Year 2021 Operating and Financial Results (GlobeNewswire)
Mar-22-22 11:11AM	Should You Buy Nyxoah (NYXH) Ahead of Earnings? (Zacks)
Mar-14-22 06:30PM	BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts (GlobeNewswire)
Mar-10-22 04:30PM	Nyxoah to Participate in the Oppenheimer 32nd Annual Healthcare Conference (GlobeNewswire)
Mar-07-22 04:30PM	Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022 (GlobeNewswire)
Mar-03-22 04:30PM	Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022 (GlobeNewswire)
Feb-11-22 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Feb-04-22 04:30PM	Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-10-22 01:00AM	Nyxoah Provides General Corporate Update (GlobeNewswire)
Nov-26-21 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-12-21 04:30PM	Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference (GlobeNewswire)
Nov-08-21 04:30PM	Nyxoah appoints new CFO (GlobeNewswire)
Nov-03-21 05:30PM	Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire)
Oct-29-21 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Oct-04-21 04:30PM	Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients (GlobeNewswire)
Oct-01-21 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Sep-14-21 02:00AM	Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse (GlobeNewswire)
Sep-13-21 04:30PM	Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference (GlobeNewswire)
Sep-12-21 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Sep-02-21 04:30PM	Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference (GlobeNewswire)
Sep-01-21 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Aug-31-21 04:30PM	Nyxoah Issues First Half 2021 Financial Results (GlobeNewswire) +10.89%
Aug-30-21 08:36AM	Should You Buy Nyxoah (NYXH) Ahead of Earnings? (Zacks)

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NYXH

Nyxoah SA

Upgrade your FINVIZ experience